Showing results (51-60 of 149) with videos related to
Sort By:
Pageof 15
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer diseaseA Sudilovsky, N R Cutler, J J Sramek, et al.Journal of Clinical Pharmacology|August 1, 1995
The safety and tolerance of xanomeline tartrate in patients with Alzheimer's diseaseJ J Sramek, D J Hurley, T S Wardle, et al.The Annals of Pharmacotherapy|June 1, 1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patientsN R Cutler, J J Sramek, A Luna, et al.Psychopharmacology Bulletin|October 8, 1999
A bridging study of fananserin in schizophrenic patientsJ J Sramek, S Kirkesseli, A Paccaly-Moulin, et al.Cephalalgia : an International Journal of Headache|April 1, 1996
Pilot study of MK-462 in migraineN R Cutler, J Claghorn, J J Sramek, et al.Antimicrobial Agents and Chemotherapy|June 1, 1997
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacinN R Cutler, J Vincent, S S Jhee, et al.Journal of Geriatric Psychiatry and Neurology|April 1, 1993
Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's typeN R Cutler, T D Fakouhi, W T Smith, et al.Acta Neurologica Scandinavica|May 12, 1998
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseN R Cutler, R J Polinsky, J J Sramek, et al.Headache|July 17, 1998
Pharmacokinetics and pharmacodynamics of avitriptan in patients with migraine after oral dosingN R Cutler, D E Salazar, S S Jhee, et al.Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.Pageof 15